Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• Intuitive Surgical, Inc. has an average analyst rating of "Moderate Buy", with 13 buy ratings, 5 hold, and 1 sell rating among 19 analysts.
• The average price target for Intuitive Surgical stock over the next 12 months is approximately $595.95, with estimates ranging from $440 to $600.
• The company reported earnings of $2.19 per share for the last quarter, exceeding the consensus estimate by $0.26 and showcasing a year-over-year revenue increase of 21.4%.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) has received an average recommendation of "Moderate Buy" from the nineteen analysts that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $595.9524.

Several analysts have recently weighed in on ISRG shares. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Truist Financial lifted their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft downgraded shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $477.08 on Friday. The company has a 50 day moving average price of $510.29 and a 200-day moving average price of $526.13. Intuitive Surgical has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company has a market capitalization of $171.02 billion, a PE ratio of 66.54, a P/E/G ratio of 5.06 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the firm posted $1.78 earnings per share. The company's revenue was up 21.4% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,839 shares of company stock valued at $7,896,972. Corporate insiders own 0.70% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently made changes to their positions in the business. Connecticut Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 9.8% during the second quarter. Connecticut Wealth Management LLC now owns 1,285 shares of the medical equipment provider's stock valued at $698,000 after buying an additional 115 shares during the last quarter. Lighthouse Investment Partners LLC grew its holdings in shares of Intuitive Surgical by 860.0% during the second quarter. Lighthouse Investment Partners LLC now owns 4,800 shares of the medical equipment provider's stock valued at $2,608,000 after buying an additional 4,300 shares during the last quarter. Florida Financial Advisors LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at $295,000. MGB Wealth Management LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at $264,000. Finally, California State Teachers Retirement System grew its holdings in shares of Intuitive Surgical by 1.8% during the second quarter. California State Teachers Retirement System now owns 560,780 shares of the medical equipment provider's stock valued at $304,733,000 after buying an additional 10,074 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.